Secondary peritonitis medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Medical Therapy ==
==Medical Therapy ==
For secondary peritonitis appropriate use of antimicrobial regimen, serves as an adjunctive treatment to surgical intervention.<ref name="pmid10583280">{{cite journal| author=Bosscha K, van Vroonhoven TJ, van der Werken C| title=Surgical management of severe secondary peritonitis. | journal=Br J Surg | year= 1999 | volume= 86 | issue= 11 | pages= 1371-7 | pmid=10583280 | doi=10.1046/j.1365-2168.1999.01258.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10583280  }} </ref>
For secondary peritonitis appropriate use of antimicrobial regimen, serves as an adjunctive treatment to surgical intervention.<ref name="pmid10583280">{{cite journal| author=Bosscha K, van Vroonhoven TJ, van der Werken C| title=Surgical management of severe secondary peritonitis. | journal=Br J Surg | year= 1999 | volume= 86 | issue= 11 | pages= 1371-7 | pmid=10583280 | doi=10.1046/j.1365-2168.1999.01258.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10583280  }} </ref>The general principles guiding the treatment of secondary peritonitis are 4-fold, as follows:
* Control the infectious source
* Eliminate bacteria and toxins
* Maintain organ system function
* Control the inflammatory process
Depending on the severity of the patient's state, the management of secondary peritonitis may include:
* General supportive measures such as vigorous [[intravenous]] [[rehydration]] and correction of [[electrolyte disturbance]]s.
* [[Antibiotics]] are usually administered [[intravenous]]ly, but they may also be infused directly into the peritoneum. The empiric choice of [[broad-spectrum antibiotics]] often consist of multiple drugs, and should be targeted against the most likely agents, depending on the cause of peritonitis; once one or more agents are actually isolated, therapy will of course be targeted on them.
* The response to therapy can be documented, if necessary, by a decrease in the PMN count of at least 50% on repeat paracentesis 48 hours after initiation of therapy.
* Probiotic supplement (containing Lactobacillus acidophilus among other species), 5 - 10 billion CFUs (colony forming units) a day, for gastrointestinal and immune health.
* Probiotics can be especially helpful when taking antibiotics, because probiotics can help restore the balance of "good" bacteria in the intestines.


==References==
==References==

Revision as of 21:31, 5 February 2017

Peritonitis main page

Secondary Peritonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Secondary peritonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Secondary peritonitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Secondary peritonitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Secondary peritonitis medical therapy

CDC on Secondary peritonitis medical therapy

Secondary peritonitis medical therapy in the news

Blogs on Secondary peritonitis medical therapy

Directions to Hospitals Treating Spontaneous bacterial peritonitis

Risk calculators and risk factors for Secondary peritonitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]

Overview

Medical management of peritonitis includes hydration, prevention of septicemia, and correction of electrolytes. Empiric coverage for gram positive, gram negative, and anaerobic bacteria should be initiated promptly while awaiting culture results. Either open abdominal surgery or an exploratory laparotomy is recommended.

Medical Therapy

For secondary peritonitis appropriate use of antimicrobial regimen, serves as an adjunctive treatment to surgical intervention.[1]The general principles guiding the treatment of secondary peritonitis are 4-fold, as follows:

  • Control the infectious source
  • Eliminate bacteria and toxins
  • Maintain organ system function
  • Control the inflammatory process

Depending on the severity of the patient's state, the management of secondary peritonitis may include:

  • General supportive measures such as vigorous intravenous rehydration and correction of electrolyte disturbances.
  • Antibiotics are usually administered intravenously, but they may also be infused directly into the peritoneum. The empiric choice of broad-spectrum antibiotics often consist of multiple drugs, and should be targeted against the most likely agents, depending on the cause of peritonitis; once one or more agents are actually isolated, therapy will of course be targeted on them.
  • The response to therapy can be documented, if necessary, by a decrease in the PMN count of at least 50% on repeat paracentesis 48 hours after initiation of therapy.
  • Probiotic supplement (containing Lactobacillus acidophilus among other species), 5 - 10 billion CFUs (colony forming units) a day, for gastrointestinal and immune health.
  • Probiotics can be especially helpful when taking antibiotics, because probiotics can help restore the balance of "good" bacteria in the intestines.

References

  1. Bosscha K, van Vroonhoven TJ, van der Werken C (1999). "Surgical management of severe secondary peritonitis". Br J Surg. 86 (11): 1371–7. doi:10.1046/j.1365-2168.1999.01258.x. PMID 10583280.


Template:WikiDoc Sources